[144] BeOne Medicines Ltd. American SEC Filing

Rhea-AI Filing Summary

BeOne Medicines Ltd. (ONC) Form 144 notifies a proposed sale of 122 American Depositary Shares (ADS) to be executed through Morgan Stanley Smith Barney LLC on 09/02/2025 on NASDAQ with an aggregate market value of $39,864.72. The filing reports the ADS were acquired on 08/31/2025 by restricted stock vesting under a registered plan and that payment/consideration is noted as Not Applicable.

The filing lists prior sales by the same person, Titus Benjamin Ball, of 134 ADS and 137 ADS on 06/11/2025 with gross proceeds of $34,620.05 and $26,021.78, respectively. Certain filer/contact fields and the notice date/signature are not populated in the provided content.

Positive

• Disclosure under Rule 144 is provided, documenting the proposed sale and prior sales
• Broker identified as Morgan Stanley Smith Barney LLC, indicating an institutional brokered transaction

Negative

• Filer contact and CIK fields are not populated in the provided excerpt
• Notice date and signature are not present in the supplied content
• Insider sold additional ADS on 06/11/2025 (134 ADS and 137 ADS), indicating prior monetization

Insights

Securities Analyst

TL;DR: Routine insider sale filing for recently vested restricted ADS, modest single-block transaction disclosed under Rule 144.

The notice documents a small proposed sale of 122 ADS via Morgan Stanley, stemming from restricted stock vesting on 08/31/2025. The transaction appears procedural: it follows Rule 144 disclosure requirements and lists recent sales by the same person on 06/11/2025. From a market-impact perspective, the filing as provided contains no earnings, material corporate events, or valuation changes; it is primarily an insider liquidity disclosure rather than a corporate development that alters the issuer’s financials.

Corporate Governance Expert

TL;DR: Disclosure shows insider monetization of vested awards; filing lacks some administrative contact and signature details in the provided extract.

The document states the ADS were acquired via restricted stock vesting and that additional ADS were sold by the same individual earlier in June 2025. Proper Rule 144 disclosure is used, and the broker is identified. However, key administrative fields in the excerpt (filer CIK/contact, notice date, and signature) are not populated in the supplied content, which limits confirmation of procedural completeness for governance review.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ADS	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	122	39864.72	54564278	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADS	08/31/2025	Restricted stock vesting under a registered plan	Issuer			122	08/31/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
TITUS BENJAMIN BALL 94 Solaris Avenue, Camana Bay Grand Cayman E9 KY1 1108	ADS	06/11/2025	134	34620.05
TITUS BENJAMIN BALL 94 Solaris Avenue, Camana Bay Grand Cayman E9 KY1 1108	ADS	06/11/2025	137	26021.78

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What ADS and quantity does BeOne Medicines (ONC) Form 144 report for sale?

The filing reports a proposed sale of 122 ADS with an aggregate market value of $39,864.72.

When is the approximate date of sale listed on the Form 144?

The filing lists the approximate date of sale as 09/02/2025.

How were the ADS acquired according to the filing?

The ADS were acquired on 08/31/2025 via restricted stock vesting under a registered plan.

Who is the broker named for the proposed sale?

The broker is Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, New York, NY.

Has the seller made recent sales of ADS before this filing?

Yes. The document reports that Titus Benjamin Ball sold 134 ADS and 137 ADS on 06/11/2025, with gross proceeds of $34,620.05 and $26,021.78.

Are there any missing administrative details in the provided Form 144?

Yes. In the supplied content the filer CIK/contact fields and the notice date/signature are not populated.